Cause of death, by non-communicable diseases, ages 15-59, male in Oman
Oman: Cause of death, by non-communicable diseases, ages 15-59, male was 39.0% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 15-59, male in Oman, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 15-59.
Analysis
Oman recorded 39.0% for cause of death, by non-communicable diseases, ages 15-59, male in 2021. That is the lowest value across all 6 years on record.
Compared with earlier readings it is down 32.9% on the previous year and down 34.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, male in Oman peaked at 69.2% in 2019 and was at its lowest, 39.0%, in 2021.
Oman ranks 139th of 185 countries on this measure, in the bottom quarter.
Cause of death, by non-communicable diseases, ages 15-59, male in Oman, year by year
| Year | % of total male deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 64.8% | — |
| 2010 | 59.9% | -7.6% |
| 2015 | 57.8% | -3.4% |
| 2019 | 69.2% | +19.7% |
| 2020 | 58.2% | -16.0% |
| 2021 | 39.0% | -32.9% |
Oman compared with similar countries
- Oman's 39.0% is below the median for high income countries, which is 67.8%, 58% of the median. (58 countries reporting)
- Oman's 39.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 48.3%, 81% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 64.8% | 64.8% | 64.8% | 1 |
| 2010s | 62.3% | 57.8% | 69.2% | 3 |
| 2020s | 48.6% | 39.0% | 58.2% | 2 |
Countries ranked near Oman
More health data for Oman
- Un projection of annual infant deaths, annual growth rate -0.8969 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3507 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 429.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 221 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.89 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0388 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, male in Oman?
- Cause of death, by non-communicable diseases, ages 15-59, male in Oman was 39.0% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, male recorded in Oman?
- The highest recorded value was 69.2% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, male recorded in Oman?
- The lowest recorded value was 39.0% in 2021.
- How does Oman rank for cause of death, by non-communicable diseases, ages 15-59, male?
- Oman ranks 139th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, male rising or falling in Oman?
- Over the last ten years it is down 34.9%. The long-run trend across the full record is falling.
- Where does this Oman data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.